A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Phase 2
Terminated
- Conditions
- Peripheral Neuropathy, Chemotherapy-induced
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-12-20
- Last Posted Date
- 2014-06-04
- Target Recruit Count
- 32
- Registration Number
- NCT00267007
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
Phase 4
Completed
- Conditions
- EpilepsySeizuresEpilepsies, PartialEpilepsy, GeneralizedSeizures, Tonic-Clonic
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 409
- Registration Number
- NCT00266604
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
Phase 3
Completed
- Conditions
- EpilepsySeizures
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 51
- Registration Number
- NCT00266591
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy
Phase 2
Completed
- Conditions
- AnemiaNeoplasms
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 86
- Registration Number
- NCT00266617
A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
Phase 3
Completed
- Conditions
- Kidney Failure, ChronicAnemia
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2010-12-03
- Target Recruit Count
- 596
- Registration Number
- NCT00261521
A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
Phase 3
Completed
- Conditions
- Alzheimer DiseaseVascular Dementia
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 593
- Registration Number
- NCT00261573
A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
Phase 3
Completed
- Conditions
- Urinary Tract InfectionsBacterial InfectionsBacteriuriaUrologic Diseases
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 603
- Registration Number
- NCT00258102
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Phase 1
Completed
- Conditions
- ContraceptionFemale Contraception
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 60
- Registration Number
- NCT00258063
A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections
Phase 3
Completed
- Conditions
- BacteriuriaPyelonephritisUrologic DiseasesNeurogenic BladderUrinary Tract Infections
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2011-05-23
- Target Recruit Count
- 578
- Registration Number
- NCT00258089
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Phase 1
Completed
- Conditions
- ContraceptionFemale Contraception
- Interventions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2012-12-12
- Target Recruit Count
- 53
- Registration Number
- NCT00258076
© Copyright 2025. All Rights Reserved by MedPath